|
Ables, A. (2004). Memantine (Namenda) for moderate to severe Alzheimer's disease. American Family Practice, 69(6),1491-2.
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., & Damaraju, C.V. (2002). Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: A randomized trial. Lancet, 359, 1283-90.
Sink, K., Holden, K., & Yaffe, K. (2005). Pharmacologic treatment of neuropsychiatric symptoms of dementia. a review of the evidence. Journal of the American Medical Association, 293(5), 596-608.
Trinh, N., Hoblyn, J., Mohanty, S., & Yaffe K. (2003). Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease. Journal of the American Medical Association, 289(2), 210-16.
Resources on Medications
Medline Plus: Drug Information
Alzheimer's Association Medication Information Fact Sheets
|